Kikuchi‐Fujimoto disease following SARS ‐ CoV ‐2 infection: A rare disease with increased incidence during the COVID ‐19 pandemic?Case Reports Published on 2024-06-192024-09-05 Journal: Respirology Case Reports [Category] update2024, [키워드] COVID‐19 Kikuchi disease Kikuchi‐Fujimoto disease Lymphadenopathy maximum SARS‐CoV‐2 [DOI] 10.1002/rcr2.1414 PMC 바로가기 [Article Type] Case Reports
Historical Evolutionary Dynamics and Phylogeography Analysis of Transmissible Gastroenteritis Virus and Porcine Deltacoronavirus: Findings from 59 Suspected Swine Viral Samples from ChinaArticle Published on 2022-08-292022-11-16 Journal: International Journal of Molecular Sciences [Category] 유전자 메커니즘, [키워드] adaptive addition America Analysis analyzed Asia Bayesian Bayesian inference caused Characteristics China coronavirus COVID-19 epidemic Cross-species transmission distribution Dynamics event Evolution evolutionary dynamics finding genetic diversity Genome sequence data genotypes highlighting Human humans infect likelihood lineages maximum measure membrane fusion Migration Pandemics PDCoV phylogeography Porcine deltacoronavirus Positive selection recent Sample spatiotemporal Spike protein Surveillance Suspected TGEV transmissible gastroenteritis virus Transmission transmission rate transmitted [DOI] 10.3390/ijms23179786 PMC 바로가기
Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failureRandomized Controlled Trial Published on 2022-08-232022-10-05 Journal: PLoS ONE [Category] SARS, 임상, [키워드] activity Adults age Cardiopulmonary changed chronic heart failure clinically cross-over discomfort Effect Ejection fraction Exercise capacity facemask healthy heart failure LVEF Mask maximum oxygen uptake Patient patients peak ventilation quantified questionnaire Randomized reduce reduction in sequence significantly significantly increased surgical transmission of SARS-CoV-2 ventricular was reduced [DOI] 10.1371/journal.pone.0269470 PMC 바로가기 [Article Type] Randomized Controlled Trial
Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis재향 군인 보건국에서 부스터 대 2-용량 mRNA 코비드-19 백신 접종의 상대적 효과: 자가 통제 위험 간격 분석Article Published on 2022-08-052022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] (Maximum 6): Covid-19 age Analysis Antigen approach booster booster vaccination calculate calculated conducted confounders Delta effective Effectiveness exposure Gain groups health administration identify Immunity individual Logistic regression main analysis maximum mRNA odds of infection Odds ratio Odds ratios omicron Omicron variants positive positive PCR Positive test predominant relative risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test Self-controlled case series Sensitivity analyses sensitivity analysis Stratification Study design vaccination Vaccine vaccine effectiveness variant veteran warehouse [DOI] 10.1016/j.vaccine.2022.06.047 PMC 바로가기 [Article Type] Article
Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada캐나다 SARS-CoV-2의 첫 두 파동의 게놈 역학Article Published on 2022-08-022022-09-11 Journal: eLife [Category] SARS, 변종, 유전자 메커니즘, 진단, [키워드] 95% confidence interval B.1.1.7 Canada circulating contributed COVID-19 COVID-19 case COVID-19 cases Critical declined descendants drastic reduction Effectiveness Epidemiology Evolutionary biology First wave Genomics global health highlighting implementation in viral increasingly India International Intervention introduced investigated likelihood lineages maximum molecular Molecular epidemiology National outbreak persistence Phylogenetic tree phylogenetics predominant Prevalence public health Public health interventions reduce reducing resulting SARS-CoV-2 SARS-CoV-2 lineage second wave Spread summer sustained the timing Transmission Travel USA variant variants of concern Viral virus viruses VOCs were used [DOI] 10.7554/eLife.73896 PMC 바로가기 [Article Type] Article
Variations of COVID-19 mortality are affected by economic disparities across countriesCOVID-19 사망률의 변화는 국가 간 경제적 격차에 영향을 받습니다.Article Published on 2022-08-012022-09-11 Journal: The Science of the total environment [Category] SARS, 변종, [키워드] Affect affected average mortality Case fatality rate case fatality rates CFRs Clinical outcome clinical outcomes country COVID-19 COVID-19 case COVID-19 disease COVID-19 mitigation COVID-19 mortality cross-sectional cross-sectional study cumulative Dashboard death decreasing dominant Economy Efficiency exhibited Factor Factors First wave health system income Income levels increase in increased mortality management maximum medical resource Mitigation Mortality mortality rate mortality rates much lower outcome patients performed Policy population density populations Prevent reduction Region reported reversed second wave situation Stage the disease time lag Transmission Turning Turning points unit variant Wave Waves WHO Worldometer [DOI] 10.1016/j.scitotenv.2022.154770 PMC 바로가기 [Article Type] Article
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2고전적 지문과 비교하여 양자에서 영감을 받은 방법을 기반으로 한 약물 용도 변경은 SARS-CoV-2에 대한 잠재적인 항바이러스제를 밝혀냅니다.Article Published on 2022-07-182022-09-11 Journal: PLoS Computational Biology [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제, [키워드] accelerated Algorithm Alpha Antiviral antiviral therapeutics approach approved B.1.1.7 B.1.351 B.1.617.2 Beta binary BMS-986094 Cell culture classical cobalamin Combination comparison Comparisons complex complexity Compound compounds computational resource computational resources COVID-19 pandemic cytotoxicity Delta demonstrated Drug repurposing DrugBank database Efficacy England evaluate form GS-6620 IC50 identify in vitro inhibit inhibited inhibitors inhibitory concentration limit maximum optimization overlap pace parameter predicted problem RdRP Remdesivir replication of SARS-CoV-2 resolved RNA-dependent RNA polymerase SARS-CoV-2 SARS-COV-2 infection screening method several variant several variants strain these compound these compounds vitamin B12 while [DOI] 10.1371/journal.pcbi.1010330 PMC 바로가기 [Article Type] Article
Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UKObservational Study Published on 2022-04-282022-10-04 Journal: International journal of population data science [Category] 임상, [키워드] all age group all age groups average British National Formulary change changes in clinical care CNS cohort analysis Community community dispensing contribute COVID-19 COVID-19 pandemic CVD decrease dispensed medication distribution dropped evaluate Impact increases in information interactive dispensing dashboard maximum medication medications morbidities National nervous outcomes pandemic provide public health raising relative System Total treated [DOI] 10.23889/ijpds.v5i4.1715 PMC 바로가기 [Article Type] Observational Study
The Interaction of Hypericin with SARS-CoV-2 Reveals a Multimodal Antiviral ActivitySARS-CoV-2와 Hypericin의 상호 작용은 다중 모드 항바이러스 활성을 나타냅니다Article Published on 2022-03-302022-09-11 Journal: ACS applied materials & interfaces [Category] SARS, 치료제, [키워드] active against activity antiviral efficacy approach broad-spectrum antivirals component Concentration conditions dark determined by evaluate fluorescence microscopy heterogeneity Hypericin Interaction maximum multiple mechanism Particles photodisinfection photodynamic therapy photosensitization photosensitization. reduce SARS-CoV-2 SARS-CoV-2 infections Treatment Vero E6 VERO E6 cells viral envelope viral particle Viral particles virus virus infectivity viruses [DOI] 10.1021/acsami.1c22439 PMC 바로가기 [Article Type] Article
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsCOVID 폐렴에서 정맥내 나파모스타트 메실레이트의 무작위 대조 시험: 안전성, 약동학 및 약력학을 조사하기 위한 1b/2a상 실험 연구Clinical Trial Published on 2022-02-012022-09-11 Journal: EBioMedicine [Category] COVID19(2023년), MERS, SARS, 바이오마커, 신약개발, 임상, 치료제, [키워드] 95% CI Administered adverse events Analysis Anti-inflammatory Anticoagulant anticoagulant effect anticoagulant effects antiviral activity assigned average characterisation Controlled trial COVID COVID-19 COVID19 creatinine credible interval demonstrated dose Edinburgh Endpoint endpoints Evidence evidence of Hospital stay hospitalised hospitalised patient Hospitalised patients inactive independent Infectious diseases intravenous intravenous infusion manuscript maximum mean difference mesylate metabolites nafamostat Nafamostat mesylate observé Odds ratio open open label Oxford oxygen Patient patients Pharmacodynamics pharmacokinetics phase Phase 2 PK data plasma platform Pneumonitis Primary outcome Primary outcomes progressed randomised randomised controlled trial Randomly rate ratio receive reported Repurposed drug Research respiratory Respiratory medicine response SARS-CoV-2/COVID-19 Seven significantly higher significantly more SOC Standard of care statistically significant difference therapy Tolerability Total Total manuscript word count. Trial university with COVID-19 [DOI] 10.1016/j.ebiom.2022.103856 PMC 바로가기 [Article Type] Clinical Trial